Rheumatoid arthritis quality measures and radiographic progression

Seminars in Arthritis and Rheumatism

Volumn 44, Issue 1, 2014, Pages 9-13

  Desai, Sonali P ^a   Liu, Chih Chin ^a   Tory, Heather ^a   Norton, Tabatha ^a   Frits, Michelle ^a   Lillegraven, Siri ^b   Weinblatt, Michael ^a   Coblyn, Jonathan ^a   Yazdany, Jinoos ^c   Shadick, Nancy ^a   Solomon, Daniel H ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b DIAKONHJEMMET HOSPITAL   (Norway)

^c UNIVERSITY OF SAN FRANCISCO   (United States)

Author keywords

Quality measures; Radiographic progression; Rheumatoid arthritis

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; ANTIRHEUMATIC AGENT;

ADULT; ARTICLE; COHORT ANALYSIS; DAS28; DISEASE ACTIVITY; FEMALE; FUNCTIONAL STATUS; HEALTH ASSESSMENT QUESTIONNAIRE; HEALTH CARE QUALITY; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY CONTROL; RADIOGRAPHY; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; SCORING SYSTEM; SERODIAGNOSIS; TOTAL SHARP SCORE; AGED; ARTHRITIS, RHEUMATOID; DISEASE COURSE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; QUALITY INDICATORS, HEALTH CARE; QUALITY OF HEALTH CARE; SEVERITY OF ILLNESS INDEX;

EID: 84905279068     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2014.01.003     Document Type: Article

References (31)

1. Desai S.P., Yazdany J. Quality measurement and improvement in rheumatology: rheumatoid arthritis as a case study. Arthritis Rheum 2011, 63:3649-3660.
2. Agency for Healthcare Research and Quality 2013. Available from: 〈〉 [cited February 20, 2013]. http://www.qualitymeasures.ahrq.gov/content.aspx?id=35512.
3. Agency for Healthcare Research and Quality. 〈〉 2013. http://www.qualitymeasures.ahrq.gov/content.aspx?id=34661.
4. Hobbs K.F., Cohen M.D. Rheumatoid arthritis disease measurement: a new old idea. Rheumatology (Oxford, England) 2012, 51(Suppl. 6):vi21-vi27.
5. Gilek-Seibert K., Prescott K., Kazi S. Outcome assessments in rheumatoid arthritis. Curr Rheumatol Rep 2013, 15:370.
6. Her M., Kavanaugh A. Patient-reported outcomes in rheumatoid arthritis. Curr Opin Rheumatol 2012, 24:327-334.
7. Coulter A., Ellins J. Effectiveness of strategies for informing, educating, and involving patients. Br Med J 2007, 335:24-27.
8. US Department of Health and Human Services. Centers for Medicare and Medicaid Services. Physician Quality Reporting System [cited]. Available from: 〈〉. http://cms.hhs.gov/PQRI/.
9. Iannaccone C.K., Lee Y.C., Cui J., Frits M.L., Glass R.J., Plenge R.M., et al. Using genetic and clinical data to understand response to disease-modifying anti-rheumatic drug therapy: data from the Brigham and Women's Hospital Rheumatoid Arthritis Sequential Study. Rheumatology (Oxford, England) 2011, 50:40-46.
10. van der Heijde D. How to read radiographs according to the Sharp/van der Heijde method. J Rheumatol 2000, 27:261-263.
11. Lillegraven S., Prince F.H., Shadick N.A., Bykerk V.P., Lu B., Frits M.L., et al. Remission and radiographic outcome in rheumatoid arthritis: application of the 2011 ACR/EULAR remission criteria in an observational cohort. Ann Rheum Dis 2012, 71:681-686.
12. Liao K.P., Weinblatt M.E., Cui J., Iannaccone C., Chibnik L.B., Lu B., et al. Clinical predictors of erosion-free status in rheumatoid arthritis: a prospective cohort study. Rheumatology (Oxford, England) 2011, 50:1473-1479.
13. Bruynesteyn K., van der Heijde D., Boers M., Saudan A., Peloso P., Paulus H., et al. Determination of the minimal clinically important difference in rheumatoid arthritis joint damage of the Sharp/van der Heijde and Larsen/Scott scoring methods by clinical experts and comparison with the smallest detectable difference. Arthritis Rheum 2002, 46:913-920.
14. Lillegraven S., van der Heijde D., Uhlig T., Kvien T.K., Haavardsholm E.A. What is the clinical relevance of erosions and joint space narrowing in RA?. Nat Rev Rheumatol 2012, 8:117-120.
15. Fransen J., Laan R.F., Van Der Laar M.A., Huizinga T.W., Van Riel P.L. Influence of guideline adherence on outcome in a randomised controlled trial on the efficacy of methotrexate with folate supplementation in rheumatoid arthritis. Ann Rheum Dis 2004, 63:1222-1226.
16. Strombeck B., Petersson I.F., Vliet Vlieland T.P. Health care quality indicators on the management of rheumatoid arthritis and osteoarthritis: a literature review. Rheumatology (Oxford, England) 2013, 29:382-390.
17. Lazar E.J., Fleischut P., Regan B.K. Quality measurement in healthcare. Ann Rev Med 2013, 64:485-496.
18. Porter ME. What is value in health care?. N Engl J Med 2010, 363:2477-2481.
19. Collier D.S., Kay J., Estey G., Surrao D., Chueh H.C., Grant R.W. A rheumatology-specific informatics-based application with a disease activity calculator. Arthritis Rheum 2009, 61:488-494.
20. Fransen J., Moens H.B., Speyer I., van Riel P.L. Effectiveness of systematic monitoring of rheumatoid arthritis disease activity in daily practice: a multicentre, cluster randomised controlled trial. Annals Rheum Dis 2005, 64:1294-1298.
21. Michaud K., Vera-Llonch M., Oster G. Mortality risk by functional status and health-related quality of life in patients with rheumatoid arthritis. J Rheumatol 2012, 39:54-59.
22. Callahan L.F., Pincus T., Huston J.W., Brooks R.H., Nance E.P., Kaye J.J. Measures of activity and damage in rheumatoid arthritis: depiction of changes and prediction of mortality over five years. Arthritis Care Res 1997, 10:381-394.
23. Pincus T., Castrejon I. MDHAQ/RAPID3 scores: quantitative patient history data in a standardized "scientific" format for optimal assessment of patient status and quality of care in rheumatic diseases. Bull NYU Hosp Jt Dis 2011, 69:201-214.
24. Studenic P.R.H., Smolen J.S., Aletaha D. Discrepancies between patients and physician in perception of rheumatoid arthritis disease activity. Arthitis Rheum 2012, 64(9):2814-2823.
25. Gossec L., Paternotte S., Aanerud G.J., Balanescu A., Boumpas D.T., Carmona L., et al. Finalisation and validation of the rheumatoid arthritis impact of disease score, a patient-derived composite measure of impact of rheumatoid arthritis: a EULAR initiative. Ann Rheum Dis 2011, 70:935-942.
26. Weinblatt M.E., Bingham C.O., Mendelsohn A.M., Kim L., Mack M., Lu J., et al. Intravenous golimumab is effective in patients with active rheumatoid arthritis despite methotrexate therapy with responses as early as week 2: results of the phase 3, randomised, multicentre, double-blind, placebo-controlled GO-FURTHER trial. Ann Rheum Dis 2013, 72:381-389.
27. Weinblatt M.E., Schiff M., Valente R., van der Heijde D., Citera G., Zhao C., et al. Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: findings of a phase IIIb, multinational, prospective, randomized study. Arthritis Rheum 2013, 65:28-38.
28. Anderson J., Caplan L., Yazdany J., Robbins M.L., Neogi T., Michaud K., et al. Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice. Arthritis Care Res 2012, 64:640-647.
29. Grigor C., Capell H., Stirling A., McMahon A.D., Lock P., Vallance R., et al. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet 2004, 364:263-269.
30. Goekoop-Ruiterman Y.P., de Vries-Bouwstra J.K., Allaart C.F., van Zeben D., Kerstens P.J., Hazes J.M., et al. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial. Arthritis Rheum 2005, 52:3381-3390.
31. Salomon-Escoto K.I., Gravallese E.M., Kay J. Assessment of control of rheumatoid arthritis disease activity. Best Pract Res Clin Rheumatol 2011, 25:497-507.